Spread the love

by James Lyons-Weiler, PhD, Popular Rationalism, ©2025

(Jun. 26, 2025) — Today, June 26, 2025, marks a watershed in the history of public health. In a decisive 5–1 vote, the U.S. Advisory Committee on Immunization Practices (ACIP) formally recommended against the continued use of thimerosal-containing influenza vaccines for children and pregnant women. While the headlines frame the moment as a capitulation to “anti-vaccine sentiment” or the result of political meddling, let us be clear: this was a reckoning and it should be viewed by the vaccine industry and medicine that the era of narrative-based policy is over. This is a victory for empirically grounded medicine—and a long-overdue course correction.

This is nothing more than hard-earned gain in the application of scientific knowledge, forged in labs, argued in courtrooms, and debated across decades of silence, censorship, and institutional inertia. It is a moment of medical humility born from the realization that children’s health is too important to be sacrificed on the altar of outdated pharmacological dogma.

A Neurotoxic Legacy Unmasked

The compound at the center of this landmark vote is thimerosal, an organomercurial preservative used in multi-dose vaccine vials. For years, federal agencies downplayed concerns about thimerosal, pointing to ethylmercury’s shorter blood half-life relative to methylmercury. But blood clearance is not brain clearance. And no amount of rhetorical hand-waving could erase the data from one pivotal study: Burbacher et al., 2005.

In this carefully designed primate study, researchers compared the disposition of methyl- and ethylmercury in infant macaques. What they found shook the foundation of vaccine toxicology: ethylmercury from thimerosal cleared the blood quickly but left behind nearly twice the amount of inorganic mercury in the brain compared to methylmercury. These deposits accumulated, and persisted.

The implications were clear. Ethylmercury behaves differently than previously assumed. It demethylates rapidly and lodges in the brain as inorganic mercury, which is neurotoxic and persistent. The result? A toxicological time bomb silently delivered to the developing nervous system, never measured by the superficial pharmacokinetics on which policy had relied.

The Fallacy of Safety by Silence

For two decades, critics of thimerosal were vilified. Their reputations were sacrificed, their motives impugned, and their science dismissed by press release rather than rebutted by data. Safety reviews were based on flawed population studies with poor exposure quantification and short follow-up. Worse, comparative pharmacokinetics in non-human primates were ignored entirely.

Today, the false consensus collapsed.

Faced with mounting evidence and a growing demand for ethical transparency, the ACIP majority chose prudence. They voted to end the recommendation for thimerosal-containing flu shots. This decision affects 60% of influenza vaccines in the U.S., and it is seismic. It means that a biologically active neurotoxin, shown to persist in the brain of infant primates, will no longer be endorsed for injection into American children and unwitting adults under the guise of necessity.

And what was the response of the lone dissenter? Data? A counter-study? A call for replication?

No. The response was to call the other committee members “childish.” This is what we have termed the Tantrum Fallacy: a rhetorical gesture in which emotion replaces argument, and name-calling substitutes for rebuttal. When an expert resorts to tone-policing rather than evidence, they have nothing left. This was not an act of authority. It was a concession.


Read the rest here.